---
title: "CRCCHEM: Net profit loss of 121 million yuan in the first half of 2025, a year-on-year reduction in loss of 28.96%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254634125.md"
description: "CRCCHEM announced that its operating revenue in the first half of 2025 was 6.896 billion yuan, a year-on-year decrease of 17.95%. The net profit attributable to shareholders of the listed company was -121 million yuan, a year-on-year reduction in losses of 28.96%. The basic earnings per share were -0.0819 yuan/share, a year-on-year increase of 28.97%"
datetime: "2025-08-26T12:39:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254634125.md)
  - [en](https://longbridge.com/en/news/254634125.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254634125.md)
generator: "portal-rs"
---

# CRCCHEM: Net profit loss of 121 million yuan in the first half of 2025, a year-on-year reduction in loss of 28.96%

CRCCHEM announced that its operating revenue in the first half of 2025 was 6.896 billion yuan, a year-on-year decrease of 17.95%. The net profit attributable to shareholders of the listed company was -121 million yuan, a year-on-year reduction in losses of 28.96%. The basic earnings per share were -0.0819 yuan/share, a year-on-year increase of 28.97%

### Related Stocks

- [301090.CN](https://longbridge.com/en/quote/301090.CN.md)

## Related News & Research

- [Copper Above $14,200 a Ton, With Global Inventory Shifts in Focus](https://longbridge.com/en/news/296771972.md)
- [Signs of Abundant Cocoa Supplies Undercut Prices](https://longbridge.com/en/news/296810940.md)
- [Weekly Recap: Two interim dividends paid and selective iron‑ore bidding](https://longbridge.com/en/news/296720277.md)
- [Avanti Helium secures up to US $10 million convertible credit facility with RiverFort Global Opportunities](https://longbridge.com/en/news/296806980.md)
- [Bravo Mining intercepts 13.44 m of magmatic sulphide mineralization grading 1.55% Ni at Luanga deposit in Brazil](https://longbridge.com/en/news/296772384.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**